Based on its current operating plans, Fulcrum continues to expect that its cash, cash equivalents, and marketable securities as of June 30, 2024 will be sufficient to fund its operating requirements into 2027.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FULC:
- Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2024
- Fulcrum Therapeutics Elects Directors and Ratifies Accountant
- Fulcrum Therapeutics to Present at the 31st Annual FSHD Society International Research Congress
- Fulcrum Therapeutics to Participate in the Goldman Sachs’ 45th Annual Global Healthcare Conference